Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
ImmunoPrecise Antibodies Ltd. (IPA) had Receiveable Turnover of 5.46 for the most recently reported fiscal year, ending 2023-04-30.
| Income Statement Financials | |
$15.55M |
|
$-19.98M |
|
$6.85M |
|
$8.70M |
|
$37.03M |
|
$-21.48M |
|
$0.60M |
|
$-20.88M |
|
$-20.88M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-21.48M |
|
$-16.45M |
|
24.90M |
|
24.90M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$12.63M |
|
$7.82M |
|
$45.91M |
|
$58.55M |
|
$4.45M |
|
$4.63M |
|
$10.60M |
|
$15.06M |
|
$43.49M |
|
$5.80M |
|
$43.49M |
|
25.05M |
|
| Cash Flow Statement Financials | |
$-14.92M |
|
$-1.48M |
|
$-0.47M |
|
$22.61M |
|
$6.29M |
|
$-16.31M |
|
$1.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.84 |
|
-- |
|
-- |
|
0.10 |
|
0.13 |
|
55.95% |
|
-138.16% |
|
-138.16% |
|
-105.81% |
|
-134.29% |
|
-128.53% |
|
$-16.05M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
4.42 |
|
|
Receiveable Turnover |
5.46 |
66.82 |
|
-45.95% |
|
-344.62% |
|
-34.13% |
|
-41.53% |
|
$1.74 |
|
$-0.64 |
|
$-0.60 |
|